SMTL ID : 4q8i.1

Crystal Structure of beta-lactamase from M.tuberculosis covalently complexed with Tebipenem

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x TEB: (4R,5S)-3-(1-(4,5-dihydrothiazol-2-yl)azetidin-3-ylthio)-5-((2S,3R)-3-hydroxy-1-oxobutan-2-yl)-4-methyl-4,5- dihydro-1H-pyrrole-2-carboxylic acid(Covalent)

TEB.1: 13 residues within 4Å: Chain A: C.43, S.44, K.47, I.77, S.102, G.104, E.142, N.146, T.191, T.192, T.211, G.212, T.213 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.77, A:I.77 Hydrogen bonds: A:S.44, A:K.47, A:S.102, A:T.211, A:T.213, A:T.213 Water bridges: A:N.146, A:N.146 Salt bridges: A:R.196, A:K.210

4 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 2 residues within 4Å: Chain A: R.39, E.153 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.39 PO4.3: 1 residues within 4Å: Chain A: E.144 3 PLIP interactions: 3 interactions with chain A Water bridges: A:R.75, A:E.144, A:E.144 PO4.4: 3 residues within 4Å: Chain A: P.176, D.178, K.179 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:D.178 Water bridges: A:K.179, A:K.179 Salt bridges: A:K.179 PO4.5: 2 residues within 4Å: Chain A: R.100, Y.101 3 PLIP interactions: 3 interactions with chain A Water bridges: A:R.100, A:Y.101 Salt bridges: A:R.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hazra, S. et al., Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the beta-lactamase from Mycobacterium tuberculosis. Biochemistry (2014)

Release Date

2014-08-20

Peptides

Beta-lactamase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-lactamase

Related Entries With Identical Sequence